Print View Attached Docs:
Alias Names: Nuclear Matrix Protein-22 Assay
Methodology: Enzyme Immunoassay (EIA)
Edit Date: 4/6/2010
Performed: Monday, Thursday
Released: 1-6 days after setup at PeaceHealth Laboratories’ reference lab
CPT Code: 86316-90
Specimen Collection Details
Collection: Single void of urine between midnight an noon.
Handling: Immediately following collection, add urine to NMP22 Urine Stabilizer Vial. Urine stabilization kit available from PeaceHealth Laboratories’ Client Services. Stabilized specimen should be blue/green in colour. Freeze.
Stability: 48 hours ambient, 72 hours refrigerated, or 1 month frozen.
Standard Volume: 5 mL stabilized urine.
Transport: Frozen on dry ice.
Comments: The NMP22® assay is intended as an aid in the management of patients with transitional cell carcinoma of the urinary tract (TCC/UT). It is used after surgical treatment to identify patients with residual or rapidly recurring TCC/UT. NOTE: Values obtained with different assay methods should not be used interchangeably. This test is done using the Matritech NMP22® Test Kit, and enzyme immunoassay (EIA) method.
Rejection Criteria: Non-stabilized urine.

Reference Range:
0.0-10.0 U/mL

PeaceHealth Laboratories